Europe Influenza Vaccine Market Size, Status and Forecast 2014-2026

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The Influenza Vaccine market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 4.4% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Influenza Vaccine Market Segmentations:

    By Player:

    • CSL

    • Altimmune

    • Folia Biotech

    • UNM Pharma

    • Shijiazhuang Yiling Pharmaceutical

    • GlaxoSmithKline

    • SK Chemicals

    • Vaccitec

    • AstraZeneca

    • Sanofi

    • Genentech

    • Green Cross

    • FluGen

    • BionVax

    • Novavax

    • Moderna Therapeutics

    • Medicago

    By Type:

    • Fluzone/Vaxigrip

    • FluMist

    • Fluarix and Flulaval

    • Anflu

    • Fluvax/Afluria

    • Flucelvax and Fluvirin

    By End-User:

    • Flucelvax and Fluvirin

    • Flucelvax and Fluvirin

    • Flucelvax and Fluvirin

    • Flucelvax and Fluvirin

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Influenza Vaccine Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Influenza Vaccine Market Size and Growth Rate of Fluzone/Vaxigrip from 2014 to 2026

    • 1.3.2 Europe Influenza Vaccine Market Size and Growth Rate of FluMist from 2014 to 2026

    • 1.3.3 Europe Influenza Vaccine Market Size and Growth Rate of Fluarix and Flulaval from 2014 to 2026

    • 1.3.4 Europe Influenza Vaccine Market Size and Growth Rate of Anflu from 2014 to 2026

    • 1.3.5 Europe Influenza Vaccine Market Size and Growth Rate of Fluvax/Afluria from 2014 to 2026

    • 1.3.6 Europe Influenza Vaccine Market Size and Growth Rate of Flucelvax and Fluvirin from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Influenza Vaccine Market Size and Growth Rate of Flucelvax and Fluvirin from 2014 to 2026

    • 1.4.2 Europe Influenza Vaccine Market Size and Growth Rate of Flucelvax and Fluvirin from 2014 to 2026

    • 1.4.3 Europe Influenza Vaccine Market Size and Growth Rate of Flucelvax and Fluvirin from 2014 to 2026

    • 1.4.4 Europe Influenza Vaccine Market Size and Growth Rate of Flucelvax and Fluvirin from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Influenza Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Influenza Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Influenza Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Influenza Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Influenza Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Influenza Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Influenza Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Influenza Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Influenza Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Influenza Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Influenza Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Influenza Vaccine Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Influenza Vaccine Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Influenza Vaccine by Major Types

      • 3.4.1 Market Size and Growth Rate of Fluzone/Vaxigrip

      • 3.4.2 Market Size and Growth Rate of FluMist

      • 3.4.3 Market Size and Growth Rate of Fluarix and Flulaval

      • 3.4.4 Market Size and Growth Rate of Anflu

      • 3.4.5 Market Size and Growth Rate of Fluvax/Afluria

      • 3.4.6 Market Size and Growth Rate of Flucelvax and Fluvirin

    4 Segmentation of Influenza Vaccine Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Influenza Vaccine by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Influenza Vaccine for Flucelvax and Fluvirin

      • 4.4.2 Market Size and Growth Rate of Influenza Vaccine for Flucelvax and Fluvirin

      • 4.4.3 Market Size and Growth Rate of Influenza Vaccine for Flucelvax and Fluvirin

      • 4.4.4 Market Size and Growth Rate of Influenza Vaccine for Flucelvax and Fluvirin

    5 Market Analysis by Major Regions

    • 5.1 Europe Influenza Vaccine Production Analysis by Top Regions

    • 5.2 Europe Influenza Vaccine Consumption Analysis by Top Regions

    • 5.3 Europe Influenza Vaccine Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Influenza Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Influenza Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.3 France Influenza Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Influenza Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Influenza Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Influenza Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Influenza Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Influenza Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Influenza Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Influenza Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Influenza Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Influenza Vaccine Production, Import, Consumption and Export Analysis

    6 Product Circulation of Influenza Vaccine Market among Top Countries

    • 6.1 Top 5 Export Countries in Influenza Vaccine Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Influenza Vaccine Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Influenza Vaccine Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Influenza Vaccine Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Influenza Vaccine Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Influenza Vaccine Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Influenza Vaccine Landscape Analysis

    • 7.1 Germany Influenza Vaccine Landscape Analysis by Major Types

    • 7.2 Germany Influenza Vaccine Landscape Analysis by Major End-Users

    8. UK Influenza Vaccine Landscape Analysis

    • 8.1 UK Influenza Vaccine Landscape Analysis by Major Types

    • 8.2 UK Influenza Vaccine Landscape Analysis by Major End-Users

    9. France Influenza Vaccine Landscape Analysis

    • 9.1 France Influenza Vaccine Landscape Analysis by Major Types

    • 9.2 France Influenza Vaccine Landscape Analysis by Major End-Users

    10. Italy Influenza Vaccine Landscape Analysis

    • 10.1 Italy Influenza Vaccine Landscape Analysis by Major Types

    • 10.2 Italy Influenza Vaccine Landscape Analysis by Major End-Users

    11. Spain Influenza Vaccine Landscape Analysis

    • 11.1 Spain Influenza Vaccine Landscape Analysis by Major Types

    • 11.2 Spain Influenza Vaccine Landscape Analysis by Major End-Users

    12. Poland Influenza Vaccine Landscape Analysis

    • 12.1 Poland Influenza Vaccine Landscape Analysis by Major Types

    • 12.2 Poland Influenza Vaccine Landscape Analysis by Major End-Users

    13. Russia Influenza Vaccine Landscape Analysis

    • 13.1 Russia Influenza Vaccine Landscape Analysis by Major Types

    • 13.2 Russia Influenza Vaccine Landscape Analysis by Major End-Users

    14. Switzerland Influenza Vaccine Landscape Analysis

    • 14.1 Switzerland Influenza Vaccine Landscape Analysis by Major Types

    • 14.2 Switzerland Influenza Vaccine Landscape Analysis by Major End-Users

    15. Turkey Influenza Vaccine Landscape Analysis

    • 15.1 Turkey Influenza Vaccine Landscape Analysis by Major Types

    • 15.2 Turkey Influenza Vaccine Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Influenza Vaccine Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Influenza Vaccine Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Influenza Vaccine Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Influenza Vaccine Landscape Analysis by Top Countries

      • 16.3.1 Denmark Influenza Vaccine Market Volume and Growth Rate

      • 16.3.2 Finland Influenza Vaccine Market Volume and Growth Rate

      • 16.3.3 Norway Influenza Vaccine Market Volume and Growth Rate

      • 16.3.4 Sweden Influenza Vaccine Market Volume and Growth Rate

      • 16.3.6 Iceland Influenza Vaccine Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Influenza Vaccine Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Influenza Vaccine Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Influenza Vaccine Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Influenza Vaccine Landscape Analysis by Top Countries

      • 17.3.1 Belgium Influenza Vaccine Market Volume and Growth Rate

      • 17.3.2 Netherlands Influenza Vaccine Market Volume and Growth Rate

      • 17.3.3 Luxembourg Influenza Vaccine Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Influenza Vaccine Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Influenza Vaccine Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Influenza Vaccine Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Influenza Vaccine Landscape Analysis by Top Countries

      • 18.3.1 Estonia Influenza Vaccine Market Volume and Growth Rate

      • 18.3.2 Latvia Influenza Vaccine Market Volume and Growth Rate

      • 18.3.3 Lithuania Influenza Vaccine Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 CSL

      • 19.1.1 CSL Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Altimmune

      • 19.2.1 Altimmune Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 Folia Biotech

      • 19.3.1 Folia Biotech Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 UNM Pharma

      • 19.4.1 UNM Pharma Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Shijiazhuang Yiling Pharmaceutical

      • 19.5.1 Shijiazhuang Yiling Pharmaceutical Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 GlaxoSmithKline

      • 19.6.1 GlaxoSmithKline Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 SK Chemicals

      • 19.7.1 SK Chemicals Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 Vaccitec

      • 19.8.1 Vaccitec Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 AstraZeneca

      • 19.9.1 AstraZeneca Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    • 19.10 Sanofi

      • 19.10.1 Sanofi Company Profile and Development Status

      • 19.10.2 Market Performance

      • 19.10.3 Product and Service Introduction

    • 19.11 Genentech

      • 19.11.1 Genentech Company Profile and Development Status

      • 19.11.2 Market Performance

      • 19.11.3 Product and Service Introduction

    • 19.12 Green Cross

      • 19.12.1 Green Cross Company Profile and Development Status

      • 19.12.2 Market Performance

      • 19.12.3 Product and Service Introduction

    • 19.13 FluGen

      • 19.13.1 FluGen Company Profile and Development Status

      • 19.13.2 Market Performance

      • 19.13.3 Product and Service Introduction

    • 19.14 BionVax

      • 19.14.1 BionVax Company Profile and Development Status

      • 19.14.2 Market Performance

      • 19.14.3 Product and Service Introduction

    • 19.15 Novavax

      • 19.15.1 Novavax Company Profile and Development Status

      • 19.15.2 Market Performance

      • 19.15.3 Product and Service Introduction

    • 19.16 Moderna Therapeutics

      • 19.16.1 Moderna Therapeutics Company Profile and Development Status

      • 19.16.2 Market Performance

      • 19.16.3 Product and Service Introduction

    • 19.17 Medicago

      • 19.17.1 Medicago Company Profile and Development Status

      • 19.17.2 Market Performance

      • 19.17.3 Product and Service Introduction

    The List of Tables and Figures (Totals 92 Figures and 114 Tables)

    • Figure Product Picture

    • Figure Europe Influenza Vaccine Market Size and Growth Rate of Fluzone/Vaxigrip from 2014 to 2026

    • Figure Europe Influenza Vaccine Market Size and Growth Rate of FluMist from 2014 to 2026

    • Figure Europe Influenza Vaccine Market Size and Growth Rate of Fluarix and Flulaval from 2014 to 2026

    • Figure Europe Influenza Vaccine Market Size and Growth Rate of Anflu from 2014 to 2026

    • Figure Europe Influenza Vaccine Market Size and Growth Rate of Fluvax/Afluria from 2014 to 2026

    • Figure Europe Influenza Vaccine Market Size and Growth Rate of Flucelvax and Fluvirin from 2014 to 2026

    • Figure Europe Influenza Vaccine Market Size and Growth Rate of Flucelvax and Fluvirin from 2014 to 2026

    • Figure Europe Influenza Vaccine Market Size and Growth Rate of Flucelvax and Fluvirin from 2014 to 2026

    • Figure Europe Influenza Vaccine Market Size and Growth Rate of Flucelvax and Fluvirin from 2014 to 2026

    • Figure Europe Influenza Vaccine Market Size and Growth Rate of Flucelvax and Fluvirin from 2014 to 2026

    • Figure Germany Influenza Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure UK Influenza Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure France Influenza Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Influenza Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Influenza Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Influenza Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Influenza Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Influenza Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Influenza Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Influenza Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Influenza Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Influenza Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Influenza Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Influenza Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Influenza Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Influenza Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Influenza Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Influenza Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Influenza Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Influenza Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Influenza Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Influenza Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Influenza Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Influenza Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Influenza Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Influenza Vaccine Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Influenza Vaccine

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Influenza Vaccine by Different Types from 2014 to 2026

    • Table Consumption Share of Influenza Vaccine by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Fluzone/Vaxigrip

    • Figure Market Size and Growth Rate of FluMist

    • Figure Market Size and Growth Rate of Fluarix and Flulaval

    • Figure Market Size and Growth Rate of Anflu

    • Figure Market Size and Growth Rate of Fluvax/Afluria

    • Figure Market Size and Growth Rate of Flucelvax and Fluvirin

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Influenza Vaccine by Different End-Users from 2014 to 2026

    • Table Consumption Share of Influenza Vaccine by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Flucelvax and Fluvirin

    • Figure Market Size and Growth Rate of Flucelvax and Fluvirin

    • Figure Market Size and Growth Rate of Flucelvax and Fluvirin

    • Figure Market Size and Growth Rate of Flucelvax and Fluvirin

    • Table Europe Influenza Vaccine Production by Major Regions

    • Table Europe Influenza Vaccine Production Share by Major Regions

    • Figure Europe Influenza Vaccine Production Share by Major Countries and Regions in 2014

    • Table Europe Influenza Vaccine Consumption by Major Regions

    • Table Europe Influenza Vaccine Consumption Share by Major Regions

    • Table Germany Influenza Vaccine Production, Import, Consumption and Export Analysis

    • Table UK Influenza Vaccine Production, Import, Consumption and Export Analysis

    • Table France Influenza Vaccine Production, Import, Consumption and Export Analysis

    • Table Italy Influenza Vaccine Production, Import, Consumption and Export Analysis

    • Table Spain Influenza Vaccine Production, Import, Consumption and Export Analysis

    • Table Poland Influenza Vaccine Production, Import, Consumption and Export Analysis

    • Table Russia Influenza Vaccine Production, Import, Consumption and Export Analysis

    • Table Switzerland Influenza Vaccine Production, Import, Consumption and Export Analysis

    • Table Turkey Influenza Vaccine Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Influenza Vaccine Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Influenza Vaccine Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Influenza Vaccine Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Influenza Vaccine Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Influenza Vaccine Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Influenza Vaccine Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Influenza Vaccine Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Influenza Vaccine Consumption by Types from 2014 to 2026

    • Table Germany Influenza Vaccine Consumption Share by Types from 2014 to 2026

    • Table Germany Influenza Vaccine Consumption by End-Users from 2014 to 2026

    • Table Germany Influenza Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table UK Influenza Vaccine Consumption by Types from 2014 to 2026

    • Table UK Influenza Vaccine Consumption Share by Types from 2014 to 2026

    • Table UK Influenza Vaccine Consumption by End-Users from 2014 to 2026

    • Table UK Influenza Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table France Influenza Vaccine Consumption by Types from 2014 to 2026

    • Table France Influenza Vaccine Consumption Share by Types from 2014 to 2026

    • Table France Influenza Vaccine Consumption by End-Users from 2014 to 2026

    • Table France Influenza Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Italy Influenza Vaccine Consumption by Types from 2014 to 2026

    • Table Italy Influenza Vaccine Consumption Share by Types from 2014 to 2026

    • Table Italy Influenza Vaccine Consumption by End-Users from 2014 to 2026

    • Table Italy Influenza Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Spain Influenza Vaccine Consumption by Types from 2014 to 2026

    • Table Spain Influenza Vaccine Consumption Share by Types from 2014 to 2026

    • Table Spain Influenza Vaccine Consumption by End-Users from 2014 to 2026

    • Table Spain Influenza Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Poland Influenza Vaccine Consumption by Types from 2014 to 2026

    • Table Poland Influenza Vaccine Consumption Share by Types from 2014 to 2026

    • Table Poland Influenza Vaccine Consumption by End-Users from 2014 to 2026

    • Table Poland Influenza Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Russia Influenza Vaccine Consumption by Types from 2014 to 2026

    • Table Russia Influenza Vaccine Consumption Share by Types from 2014 to 2026

    • Table Russia Influenza Vaccine Consumption by End-Users from 2014 to 2026

    • Table Russia Influenza Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Influenza Vaccine Consumption by Types from 2014 to 2026

    • Table Switzerland Influenza Vaccine Consumption Share by Types from 2014 to 2026

    • Table Switzerland Influenza Vaccine Consumption by End-Users from 2014 to 2026

    • Table Switzerland Influenza Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Influenza Vaccine Consumption by Types from 2014 to 2026

    • Table Turkey Influenza Vaccine Consumption Share by Types from 2014 to 2026

    • Table Turkey Influenza Vaccine Consumption by End-Users from 2014 to 2026

    • Table Turkey Influenza Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Influenza Vaccine Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Influenza Vaccine Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Influenza Vaccine Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Influenza Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Influenza Vaccine Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Influenza Vaccine Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Influenza Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Influenza Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Influenza Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Influenza Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Influenza Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Influenza Vaccine Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Influenza Vaccine Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Influenza Vaccine Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Influenza Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Influenza Vaccine Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Influenza Vaccine Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Influenza Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Influenza Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Influenza Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Influenza Vaccine Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Influenza Vaccine Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Influenza Vaccine Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Influenza Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Influenza Vaccine Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Influenza Vaccine Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Influenza Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Influenza Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Influenza Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of CSL

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of CSL

    • Figure Sales and Growth Rate Analysis of CSL

    • Figure Revenue and Market Share Analysis of CSL

    • Table Product and Service Introduction of CSL

    • Table Company Profile and Development Status of Altimmune

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Altimmune

    • Figure Sales and Growth Rate Analysis of Altimmune

    • Figure Revenue and Market Share Analysis of Altimmune

    • Table Product and Service Introduction of Altimmune

    • Table Company Profile and Development Status of Folia Biotech

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Folia Biotech

    • Figure Sales and Growth Rate Analysis of Folia Biotech

    • Figure Revenue and Market Share Analysis of Folia Biotech

    • Table Product and Service Introduction of Folia Biotech

    • Table Company Profile and Development Status of UNM Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of UNM Pharma

    • Figure Sales and Growth Rate Analysis of UNM Pharma

    • Figure Revenue and Market Share Analysis of UNM Pharma

    • Table Product and Service Introduction of UNM Pharma

    • Table Company Profile and Development Status of Shijiazhuang Yiling Pharmaceutical

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Shijiazhuang Yiling Pharmaceutical

    • Figure Sales and Growth Rate Analysis of Shijiazhuang Yiling Pharmaceutical

    • Figure Revenue and Market Share Analysis of Shijiazhuang Yiling Pharmaceutical

    • Table Product and Service Introduction of Shijiazhuang Yiling Pharmaceutical

    • Table Company Profile and Development Status of GlaxoSmithKline

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline

    • Figure Sales and Growth Rate Analysis of GlaxoSmithKline

    • Figure Revenue and Market Share Analysis of GlaxoSmithKline

    • Table Product and Service Introduction of GlaxoSmithKline

    • Table Company Profile and Development Status of SK Chemicals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of SK Chemicals

    • Figure Sales and Growth Rate Analysis of SK Chemicals

    • Figure Revenue and Market Share Analysis of SK Chemicals

    • Table Product and Service Introduction of SK Chemicals

    • Table Company Profile and Development Status of Vaccitec

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Vaccitec

    • Figure Sales and Growth Rate Analysis of Vaccitec

    • Figure Revenue and Market Share Analysis of Vaccitec

    • Table Product and Service Introduction of Vaccitec

    • Table Company Profile and Development Status of AstraZeneca

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca

    • Figure Sales and Growth Rate Analysis of AstraZeneca

    • Figure Revenue and Market Share Analysis of AstraZeneca

    • Table Product and Service Introduction of AstraZeneca

    • Table Company Profile and Development Status of Sanofi

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi

    • Figure Sales and Growth Rate Analysis of Sanofi

    • Figure Revenue and Market Share Analysis of Sanofi

    • Table Product and Service Introduction of Sanofi

    • Table Company Profile and Development Status of Genentech

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Genentech

    • Figure Sales and Growth Rate Analysis of Genentech

    • Figure Revenue and Market Share Analysis of Genentech

    • Table Product and Service Introduction of Genentech

    • Table Company Profile and Development Status of Green Cross

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Green Cross

    • Figure Sales and Growth Rate Analysis of Green Cross

    • Figure Revenue and Market Share Analysis of Green Cross

    • Table Product and Service Introduction of Green Cross

    • Table Company Profile and Development Status of FluGen

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of FluGen

    • Figure Sales and Growth Rate Analysis of FluGen

    • Figure Revenue and Market Share Analysis of FluGen

    • Table Product and Service Introduction of FluGen

    • Table Company Profile and Development Status of BionVax

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of BionVax

    • Figure Sales and Growth Rate Analysis of BionVax

    • Figure Revenue and Market Share Analysis of BionVax

    • Table Product and Service Introduction of BionVax

    • Table Company Profile and Development Status of Novavax

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novavax

    • Figure Sales and Growth Rate Analysis of Novavax

    • Figure Revenue and Market Share Analysis of Novavax

    • Table Product and Service Introduction of Novavax

    • Table Company Profile and Development Status of Moderna Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Moderna Therapeutics

    • Figure Sales and Growth Rate Analysis of Moderna Therapeutics

    • Figure Revenue and Market Share Analysis of Moderna Therapeutics

    • Table Product and Service Introduction of Moderna Therapeutics

    • Table Company Profile and Development Status of Medicago

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Medicago

    • Figure Sales and Growth Rate Analysis of Medicago

    • Figure Revenue and Market Share Analysis of Medicago

    • Table Product and Service Introduction of Medicago

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.